Abrdn Property: Custodian slams Urban’s rival offer as risky
Ahead of Abrdn Property Income’s shareholder vote on 20 March, Custodian Property Income claims its recommended all-share offer is ‘superior’ to Urban Logistics.
Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.
Ahead of Abrdn Property Income’s shareholder vote on 20 March, Custodian Property Income claims its recommended all-share offer is ‘superior’ to Urban Logistics.
Royalty fund’s board says dividends will not be reinstated as it urgently prioritises debt repayment after Shot Tower Capital, its new valuer, knocks $700m off the songs portfolio.
Bellevue Healthcare Trust (BBH) released its annual report for the 12 months ending 30 November 2023. Over the period BBH reported a negative NAV tota...
The board of Digital 9 Infrastructure (DGI9) has provided a progress update on the closing conditions required for the sale of the Verne Global group ...
Royalty fund’s board says dividends will not be reinstated as it urgently prioritises debt repayment.
Hipgnosis Songs Fund (SONG) provided an update on its valuations. During the release of its interim results, the board stated that there were multiple...
In QuotedData’s morning briefing 4 March 2024: Princess Private Equity Holding (PEY) announced its NAV performance for January, increasing 0.8% to €14...
Ruffer Investment Company spends almost £17m in first share buyback programme after worst year of performance in its 20 years, with assets down 6.2% and stock dropping 10.6%.
Super Tuesday is almost upon us, a pivotal moment in the political calendar of the United States, as it is the day in which the greatest number of US ...
Barnaby Wilson and Louis Florentin-Lee put quality growth stamp on Mid Wynd International after cutting majority of stocks they inherited from Simon Edelsten and Alex Illingworth last year.
Thank you to everyone that listened in today, whether you watched the Zoom live or on YouTube. In this week’s show, Matthew Read covered the week’s to...
Interest rate pressures are easing on biotechnology, allowing the strong fundamentals of drug development to shine, say International Biotechnology Trust fund managers Ailsa Craig and Marek Poszepczynski.
Developed by Moore-Wilson